miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ
Citations Over TimeTop 10% of 2014 papers
Abstract
MicroRNA-191 (miR-191), a small non-coding RNA, is involved in disease development and cancer diagnosis and prognosis. However, how miR-191 functions in colorectal cancer remains largely unclear. In this study, we show that miR-191 is highly expressed in colon tumor tissues, and that inhibition of miR-191 leads to decreased cell growth, proliferation and tumorigenicity in a xenograft model. Overexpression of miR-191 in colorectal cancer cell lines alters cell cycle progression and cell resistance to 5-Fu induced cell apoptosis. Mechanistic studies demonstrated that miR-191 directly binds to the 3'UTR of the C/EBPβ mRNA and mediates a decrease in the mRNA and protein expression of C/EBPβ. We further showed that C/EBPβ induces growth arrest in a colorectal cancer cell line and that its expression is negatively correlated with the miR-191 level in patient samples. Our findings suggest that miR-191 may be a potential gene therapy target for the treatment of colorectal cancer.
Related Papers
- → Potential role of micro‐RNAs in head and neck tumorigenesis(2010)64 cited
- → MicroRNA-21 versus microRNA-34: Lung cancer promoting and inhibitory microRNAs analysed in silico and in vitro and their clinical impact(2017)22 cited
- → A cell cycle hypothesis of cooperative oncogenesis (Review)(2007)23 cited
- → Potential MicroRNA Targets for Cancer Chemotherapy(2013)19 cited
- New role of microRNA： carcinogenesis and clinical application in cancer(2011)